Abstract Treatment of liver cancer and other diseases are a challenging task for the current
researchers in the pharmaceutical field. There are some physiological barriers like RES …

One of the most important health problems in the world today is cancer. The World Health
Organization (WHO) reported that it results in 8.9 million deaths annually. Malignant tumours …

Background: The pathogenesis of hepatic diseases involves several cells, which
complicates the delivery of pharmaceutical agents. Many severe liver diseases affecting the …

Liver cancer is one of serious diseases which threaten human life and health. Studies on the
treatment of liver cancer have attracted widespread attention. Application of nano-drug …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …

Hepatocellular carcinoma (HCC) is the primary liver cancer that has shown a high incidence
and mortality rate worldwide among several types of cancers. A large variety of …

Hepatocellular carcinoma (HCC) has a fairly high morbidity and is notoriously difficult to treat
due to long latent period before detection, multidrug resistance and severe drug-related …

The requirement of having multiple nanocarriers (NCs) and active agents for improved
therapy, imaging, and controlled release of medications efficiently in one platform has made …

The development of therapeutics and theranostic nanodrug delivery systems have posed a
challenging task for the current researchers due to the requirement of having various …

Background Pancreatic cancer is expected to replace lung cancer as the second greatest
cause of cancer mortality by 2025. It has been a particularly the most lethal kind of cancer …